TD Waterhouse Canada Inc. - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 39 filers reported holding DIAMEDICA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 3.16 and the average weighting 0.1%.

Quarter-by-quarter ownership
TD Waterhouse Canada Inc. ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,810
-40.7%
1,5700.0%0.00%
Q2 2023$8,114
+161.4%
1,5700.0%0.00%
Q1 2023$3,104
+6.8%
1,5700.0%0.00%
Q4 2022$2,906
+20.6%
1,5700.0%0.00%
Q3 2022$2,410
-38.1%
1,5700.0%0.00%
Q2 2022$3,892
-16.8%
1,5700.0%0.00%
Q1 2022$4,677
-43.9%
1,570
-14.7%
0.00%
Q4 2021$8,3301,8400.00%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 233,730$369,2930.45%
COOPERMAN LEON G 812,508$1,283,8440.08%
CATALYST FINANCIAL PARTNERS LLC 14,475$22,8720.01%
Legend Financial Advisors, Inc. 1,000$1,5800.00%
GEODE CAPITAL MANAGEMENT, LLC 184,870$2920.00%
STATE STREET CORP 133,258$210,5480.00%
MORGAN STANLEY 55,201$87,2230.00%
BlackRock Inc. 69,937$110,5080.00%
Bank of New York Mellon Corp 36,062$56,9820.00%
Citadel Advisors 1,600$2,5280.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders